This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Nov;15(11):1803-4.

doi: 10.1038/sj.leu.2402274.

Inappropriate reporting and interpretation of subgroups in the AML-BFM 93 study

K Wheatley, R K Hills

PMID: 11681429
DOI: 10.1038/sj.leu.2402274

Comment

Inappropriate reporting and interpretation of subgroups in the AML-BFM 93 study

K Wheatley et al. Leukemia. 2001 Nov.

. 2001 Nov;15(11):1803-4.

doi: 10.1038/sj.leu.2402274.

Authors

K Wheatley, R K Hills

PMID: 11681429
DOI: 10.1038/sj.leu.2402274

No abstract available

PubMed Disclaimer

Comment on

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group.
Creutzig U, Ritter J, Zimmermann M, Hermann J, Gadner H, Sawatzki DB, Niemeyer CM, Schwabe D, Selle B, Boos J, Kühl J, Feldges A. Creutzig U, et al. Leukemia. 2001 Mar;15(3):348-54. doi: 10.1038/sj.leu.2402046. Leukemia. 2001. PMID: 11237056 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group